About Orthomimetics
Orthomimetics is a company based in Cambridge (United Kingdom) founded in 2005 was acquired by TiGenix in November 2009.. Orthomimetics has raised $9.6 million across 1 funding round from investors including Schroders, TiGenix and Oxford Capital. The company has 2 employees as of January 31, 2022. Orthomimetics operates in a competitive market with competitors including Horizon Therapeutics, Kerecis, Histogenics, Osteal Therapeutics and Sofregen, among others.
- Headquarter Cambridge, United Kingdom
- Employees 2 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Orthomimetics Limited
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Orthomimetics
Orthomimetics has successfully raised a total of $9.6M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.6 million completed in December 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $9.6M
-
First Round
First Round
(05 Dec 2006)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2006 | Amount | Series A - Orthomimetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orthomimetics
Orthomimetics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Schroders, TiGenix and Oxford Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital is invested in UK technology sectors.
|
Founded Year | Domain | Location | |
|
Investment management and wealth management services are provided to clients.
|
Founded Year | Domain | Location | |
|
Allogeneic stem cell-based therapies targeting autoimmune, inflammatory and heart diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orthomimetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orthomimetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orthomimetics Comparisons
Competitors of Orthomimetics
Orthomimetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Kerecis, Histogenics, Osteal Therapeutics and Sofregen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| domain | founded_year | HQ Location |
Restorative cell therapies for orthopedic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Injectable synthetic bone substitutes are developed for fracture treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Orthomimetics
When was Orthomimetics founded?
Orthomimetics was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is Orthomimetics located?
Orthomimetics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Orthomimetics a funded company?
Orthomimetics is a funded company, having raised a total of $9.6M across 1 funding round to date. The company's 1st funding round was a Series A of $9.6M, raised on Dec 05, 2006.
How many employees does Orthomimetics have?
As of Jan 31, 2022, the latest employee count at Orthomimetics is 2.
What does Orthomimetics do?
Orthomimetics is a medical technology company founded as a spin-out from the University of Cambridge and the Massachusetts Institute of Technology (MIT). It combines three natural biomaterials collagen, glycosaminoglycans and calcium phosphate into bioresorbable tissue-regeneration scaffolds. The companys flagship product Chondromimetic is an off-the-shelf, resorbable implant for the minimally invasive repair of small osteochondral (cartilage and underlying bone) defects. The product has received European market approval (CE-Mark approval). Orthomimetics, is acquired by Belgium-based TiGenix for 23.8m.
Who are the top competitors of Orthomimetics?
Orthomimetics's top competitors include Horizon Therapeutics, Kerecis and BONESUPPORT.
Who are Orthomimetics's investors?
Orthomimetics has 3 investors. Key investors include Schroders, TiGenix, and Oxford Capital.